The impact of tumor stroma on drug response in breast cancer

Jürgen Dittmer1, Benjamin Leyh1

  • 1Clinic for Gynecology, University of Halle, Halle/Saale, Germany.

Insights

Drug resistance in breast cancer is a major challenge, even with improved treatments. The tumor microenvironment significantly influences how different breast cancer subtypes respond to therapies, impacting treatment effectiveness.

Area of Science:

  • Oncology
  • Cancer Biology
  • Pharmacology

Background:

  • Breast cancer mortality has decreased due to advanced treatments.
  • Drug resistance remains a significant obstacle in effective breast cancer therapy.
  • Resistance can be intrinsic to cancer cells or influenced by the tumor microenvironment.

Purpose of the Study:

  • To review the tumor microenvironment's role in breast cancer drug resistance.
  • To analyze how the tumor microenvironment affects responses to targeted drugs and chemotherapy.
  • To explore differential responses across breast cancer subtypes.

Main Methods:

  • Literature review of recent studies on breast cancer, tumor microenvironment, and drug resistance.
  • Analysis of mechanisms by which the tumor microenvironment modulates therapeutic responses.
  • Synthesis of findings related to various breast cancer subtypes.

Main Results:

  • The tumor microenvironment plays a critical role in the development of drug resistance.
  • Specific components of the microenvironment can promote resistance to targeted therapies and chemotherapy.
  • Breast cancer subtypes exhibit varying sensitivities to drugs based on their microenvironmental interactions.

Conclusions:

  • Targeting the tumor microenvironment may offer novel strategies to overcome drug resistance.
  • Understanding subtype-specific microenvironmental influences is crucial for personalized breast cancer treatment.
  • Further research into the tumor microenvironment is essential for improving patient outcomes.

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.3K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.3K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.0K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
2.6K